Business
Jayson Tatum wearing Nike during the 2021 Olympics in Tokyo
Jayson Tatum wearing Nike during the 2021 Olympics in Tokyo. (Getty Images)

Even the 2024 Paris Olympics can’t save Nike

Stock plunges 20% as the company forecasts its first decline for an Olympic quarter in decades

Nike’s stock is getting hammered Friday, dropping 20% after the company gave underwhelming guidance for its new fiscal year and said fourth-quarter sales fell more than expected. During the earnings call, CFO Matthew Friend dropped a bomb: Nike’s sales during its current quarter – the one that will include the next Olympic Games in Paris – are expected to drop 10%.

That would be the first time Nike’s sales fell during an Olympic quarter since at least the turn of the century. An analysis of financial data going back to the 2000 summer games in Sydney shows that Nike’s sales during Olympic quarters have risen an average of 9.9%, slightly higher than an average of 7.9% during non-Olympic quarters. So a drop of 10% is especially abnormal. 

Olympic season is usually a time when consumers around the world are inundated with Swooshes slapped across athletes’ uniforms, warmups, and shoes. The Team USA online store and Nike.com are already chock full of Nike Olympics gear. But after their new track and field uniforms were called too revealing even for professionals, it seems consumers may be hesitant to add to their carts. Following the recent new Major League Baseball uniforms debacle, it’s not a good look for the brand. 

“We're very excited about the Olympics coming,” Nike CEO John Donahoe said early in the call. Later, he added: “We can't wait to bring all this Olympics product to life across the games and in more than 8,000 doors worldwide. And throughout, our brand storytelling will be bold and clear, with sport and athletes at the very center of it all, from brand voice to retail activations.”

But those potential “retail activations” didn’t matter nearly as much as the revenue forecast to investors, who slashed some $28 billion off Nike’s market cap as of midday Friday.

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.